Arquivos Brasileiros de Endocrinologia & Metabologia · 2014 · 11 citations · 9 references
MedicinePharmacotherapyClinical PharmacologyHemodialysisTransfusion MedicineAcid-base ManagementPatient Blood ManagementFresh Frozen Plasma TherapyMechanical Ventilation ManagementMetabolic Crisis ManagementPropionic AcidemiaSodium Bicarbonate Therapy
OBJETIVO: To evaluate the therapeutic agents used during metabolic crises and in long-term management of patients with propionic acidemia (PA). MATERIALS AND METHODS: The records of PA patients were retrospectively evaluated. RESULTS: The study group consisted of 30 patients with 141 admissions. During metabolic crises, hyperammonemia was found in 130 (92%) admissions and almost all patients were managed with normal saline, ≥ 10% dextrose, and restriction of protein intake. In 56 (40%) admissions, management was done in intensive care unit, 31 (22%) with mechanical ventilation, 10 (7%) with haemodialysis, 16 (11%) with vasopressor agents, and 12 (9%) with insulin. In the rescue procedure, L-carnitine was used in 135 (96%) patients, sodium bicarbonate in 116 (82%), sodium benzoate in 76 (54%), and metronidazole in 10 (7%), biotin in about one-quarter, L-arginine in one third, and antibiotics in three-quarter of the admissions. Blood/packed RBCs were used in 28 (20%) patients, platelets in 26 (18%), fresh frozen plasma in 8 (6%), and granulocyte-colony stimulating factors in 10 (7%) admissions. All patients were managed completely/partially with medical nutrition formula plus amino acid mixture, vitamins and minerals. For long-term management 24 (80%) patients were on L-carnitine, 22 (73%) on sodium benzoate, 6 (20%) on biotin, one half on alkaline therapy and 4 (13%) on regular metronidazole use. Almost all patients were on medical formula and regular follow-up. CONCLUSION: Aggressive and adequate management of acute metabolic crises with restriction of protein intake, stabilization of patient, reversal of catabolism, and removal of toxic metabolites are essential steps. Concerted efforts to ensure adequate nutrition, to minimize the risk of acute decompensation and additional therapeutic advances are imperative to improve the outcome of PA patients.
9
Inborn Metabolic Diseases: Diagnosis and Treatment
J Zeman · Acta Paediatrica · 2012 · 212 citations
CT and MR of the brain in disorders of the propionate and methylmalonate metabolism.
J. Brismar, Pinar T. Ozand · PubMed · 1994 · 121 citations · Full text
Medicine, Neurology, Pediatrics +14
Propionic acidaemia: clinical, biochemical and therapeutic aspects
W. Lehnert, Wolfgang Sperl, Terttu Suormala et al. · European Journal of Pediatrics · 1994 · 121 citations
Mendel Tuchman, Ljubica Caldovic, Yevgeny Daikhin et al. · Pediatric Research · 2008 · 89 citations · Full text